Drug Approval | April 21, 2025
FDA approves Medtronic’s new Simplera Sync sensor for the MiniMed 780G system
The Simplera Sync is a disposable, all-in-one sensor that requires no fingersticks with SmartGuard
The Simplera Sync is a disposable, all-in-one sensor that requires no fingersticks with SmartGuard
SmartTrack aims to reduce the need for clinical studies in generic drug product approvals
According to IQVIATM sales data for the 12-month period ending February 2025, the Adderall Tablets, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg market3 achieved annual sales of approximately $421.7 million.
Anushree has been with Abbott since 2021 and currently serving as Head of Strategy and Portfolio
The approved product, Mesalamine Suppositories 1000 mg, has an estimated U.S. market size of US$ 29 million
This change is subject to the approval of the shareholders of the company, the Ministry of Corporate Affairs and other statutory and regulatory authorities,
YESAFILI, a vascular endothelial growth factor (VEGF) inhibitor, is used to treat several different types of ophthalmology conditions
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
Padmanabhan brings over two decades of extensive experience in FMCG sector
The product will be launched in Q1FY26
Subscribe To Our Newsletter & Stay Updated
